Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
---|---|---|---|---|---|---|---|---|---|---|
North America (Primary) | PRIMARYNOAM | Univ | 8,145 | 59,660,955 | 0.15% | 1.60% | 6.01% | 6.51% | 16.95% | 26.43% |
Healthcare | HEALTHCARE | Sector | 1,333 | 6,612,544 | 0.02% | 1.84% | 6.01% | 1.11% | 14.01% | 14.79% |
Biopharmaceuticals | BIOPHARMA | SubSec | 675 | 3,052,063 | -0.14% | 2.02% | 4.26% | -1.18% | 23.58% | 30.63% |
Non-System-Specific Biopharmaceuticals | BIOPHARMANONSYS | Industry | 254 | 341,049 | -0.61% | 2.71% | 4.23% | -3.26% | 1.06% | -13.34% |
Infectious Disease Biopharmaceuticals | INFECTIOUS | SubInd | 59 | 158,942 | -0.33% | 6.85% | 12.68% | 4.42% | 1.79% | -14.52% |
Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
---|---|---|---|---|---|---|---|---|---|---|
S&P 500 | SPY:USASPY:USA | Benchmark | 14,703 | 77,878,209 | 0.14% | 1.65% | 5.99% | 6.91% | 18.44% | 28.12% |
Infectious Disease Biopharmaceuticals | INFECTIOUS | SubInd | 59 | 158,942 | -0.33% | 6.85% | 12.68% | 4.42% | 1.79% | -14.52% |
Gilead Sciences, Inc. | GILD:USAGILD:USA | Stock | 1 | 84,379 | -0.21% | 2.67% | 2.36% | -5.03% | -7.36% | -10.00% |
Moderna, Inc. | MRNA:USAMRNA:USA | Stock | 1 | 50,901 | 0.17% | 13.29% | 30.29% | 52.78% | 73.61% | 6.04% |
Vaxcyte, Inc. | PCVX:USAPCVX:USA | Stock | 1 | 8,110 | -1.17% | 14.39% | 23.01% | 0.63% | 48.87% | 53.34% |
Insmed, Inc. | INSM:USAINSM:USA | Stock | 1 | 3,680 | -1.31% | -4.62% | -0.12% | -15.20% | 1.35% | 31.62% |
Novavax, Inc. | NVAX:USANVAX:USA | Stock | 1 | 1,826 | -9.65% | 46.51% | 234.45% | 215.01% | 123.16% | 75.34% |
Dynavax Technologies Corp. | DVAX:USADVAX:USA | Stock | 1 | 1,454 | -1.51% | 3.54% | -2.03% | -9.53% | -17.89% | 1.37% |
Tarsus Pharmaceuticals, Inc. | TARS:USATARS:USA | Stock | 1 | 1,444 | -0.88% | 3.35% | 16.41% | 25.71% | 115.68% | 137.07% |
Vir Biotechnology, Inc. | VIR:USAVIR:USA | Stock | 1 | 1,322 | -2.01% | 3.07% | 22.24% | -4.89% | 0.93% | -60.91% |
Arcturus Therapeutics Holdings, Inc. | ARCT:USAARCT:USA | Stock | 1 | 802 | -2.36% | 9.24% | 13.15% | -17.76% | 34.27% | 7.90% |
CureVac NV | CVAC:USACVAC:USA | Stock | 1 | 782 | 0.29% | 19.93% | 43.03% | 0.58% | -36.31% | -60.16% |
HilleVax, Inc. | HLVX:USAHLVX:USA | Stock | 1 | 777 | 1.73% | 14.45% | 33.56% | 5.88% | 18.30% | -0.38% |
SIGA Technologies, Inc. | SIGA:USASIGA:USA | Stock | 1 | 541 | -3.67% | 2.01% | -7.53% | 61.14% | 59.87% | 41.83% |
* Colors indicate performance relative to the benchmark.